Biopharma contributes to key global health discussions at WHA69
Find out here our take on the 69th World Health Assembly (WHA69) with some key relevant links included!
Read More
Pharmacovigilance of biotherapeutic medicines
A new study released in June 2016 identifying global case studies illustrating successes and challenges. A must read!
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2018-09-27 17:57:02
The R&D-based biopharmaceutical industry welcomes the UN Declaration on NCDs and calls for innovative financing models and multi-sectoral collaboration
New York, 27 September 2018 – As an official UN interlocutor that shares knowledge and expertise to improve global health, ...
Read More2018-09-26 22:55:14
R&D-based biopharmaceutical industry welcomes UN Declaration on TB Partnerships are key to foster innovation and access
Geneva, 26 September 2018 – Today, at the first-ever United Nations (UN) High-Level Meeting on ...
Read More2018-09-25 10:21:12
WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
PR/2018/820 Released jointly by WIPO and IFPMA GENEVA, September 25, 2018 – WIPO and the ...
Read More2018-09-19 16:37:06
Ghana plays host to major African healthcare business integrity and ethics forum
Over a hundred Pharma industry management and healthcare professionals, medical and scientific advisors receive training ...
Read More2018-05-28 07:13:31
The R&D-based pharmaceutical industry supports the World Health Organization 5-year work plan and welcomes new era on health partnerships
28 May 2018, Geneva – IFPMA, the voice of the biopharmaceutical innovation and health progress ...
Read More2018-05-25 10:56:58
IFPMA Welcomes Set-Up of New African Medicines Agency
Geneva, 25 May 2018 – To mark Africa Day, soon after African health ministers of ...
Read More2018-05-24 10:34:13
International Alliance of Patients’ Organizations joins Fight the Fakes as 36th partner
Thursday, 24th May, Miami – Fight the Fakes is proud to announce that the International ...
Read More
Latest Statement
2018-10-12 14:58:26
R&D biopharmaceutical industry at WHS 2018 urges finding joint solutions to achieve better health outcomes including forging impactful partnerships
Sunday, 14 October 2018, Berlin – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the body accredited by the ...
Read More2018-10-04 16:50:33
Global Business Coalition - Knowledge Partners of Global Health & Human Resources Knowledge Partnership Issue Statement
Thursday, 24th May, Miami – Fight the Fakes is proud ...
Read More2018-09-27 17:58:18
R&D-based biopharmaceutical industry welcomes UN Declaration on NCDs
Thursday, 24th May, Miami – Fight the Fakes is proud ...
Read More2018-09-26 22:55:57
R&D-based biopharmaceutical industry welcomes UN Declaration on TB
Thursday, 24th May, Miami – Fight the Fakes is proud ...
Read More2018-09-20 10:31:00
68th WHO Regional Committee for Europe: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines
Thursday, 24th May, Miami – Fight the Fakes is proud ...
Read More2018-08-30 14:17:00
WHO Afro 68 agenda item 12: Status of implementation of the four time-bound commitments on noncommunicable diseases in the Africa region
Thursday, 24th May, Miami – Fight the Fakes is proud ...
Read More2018-08-30 14:16:42
WHO Afro 68 agenda item 14: Roadmap for access 2019–2023: Comprehensive support for access to medicines and vaccines
Thursday, 24th May, Miami – Fight the Fakes is proud ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
The fight against Zika: Harnessing partnerships and innovative production processes
Here we explore Takeda’s efforts to develop a Zika vaccine and the crucial role vaccine development programs play in tackling emerging diseases. Laurence De Moerlooze, Vice President & Global Lead Zika, Takeda Vaccines; Gary Dubin, Senior Vice President and Head of the Global Medical Office, Takeda Vaccines; and Rahul Singhvi, Chief Operating Officer, Takeda Vaccines, underline the importance of partnerships and innovation in Takeda’s efforts....
Read More
New IFPMA Code of Practice 2019
This oped was first published in the World Medical Journal (Vol. 64, September2018). An efficient healthcare system depends on mutual trust between all parties – but how should that translate concretely into the day to day reality of whether a healthcare professional should be given a subscription to a journal or a box of chocolates by a pharmaceutical company? So while the most important part...
Read More
Risks And Ultimate Rewards: Innovative Ways To Beat Chronic Diseases
This oped was first published on Health Policy Watch on 28 September 2018. It’s often hard to see progress when the realities surrounding you are bleak: non-communicable diseases (NCDs) are the world’s biggest killer, responsible for around 70 percent of global deaths. Each year some 40 million people die of such chronic diseases as cardiovascular failure, cancer, respiratory illnesses and diabetes: the four main killers....
Read MoreLatest Tweets
@IFPMA @IFPMA @IFPMA @IFPMA @IFPMA 